Angiotensin I (1-7)
Showing 1 - 25 of >10,000
Hypertension, Hypertension, Essential Trial in Nashville (Angiotensin (1-7), Trimethaphan, Phenylephrine)
Active, not recruiting
- Hypertension
- Hypertension, Essential
- Angiotensin (1-7)
- +2 more
-
Nashville, TennesseeVanderbilt University
Jan 2, 2023
Obesity, Insulin Resistance, Hypertension Trial in Nashville (Angiotensin-(1-7), Saline)
Recruiting
- Obesity
- +3 more
-
Nashville, TennesseeVanderbilt University School of Medicine
Jan 18, 2022
Obesity Trial in Hershey (Angiotensin-(1-7), Saline)
Recruiting
- Obesity
-
Hershey, PennsylvaniaPenn State Milton S. Hershey Medical Center
Dec 1, 2022
Aging Trial in Hershey (Angiotensin-(1-7), Saline)
Not yet recruiting
- Aging
-
Hershey, PennsylvaniaPenn State Milton S. Hershey Medical Center
Jul 12, 2022
Infection, Coronavirus, Respiratory Failure Trial in Belo Horizonte (Angiotensin-(1-7), Placebo)
Completed
- Infection, Coronavirus
- Respiratory Failure
- Angiotensin-(1-7)
- Placebo
-
Belo Horizonte, Minas Gerais, Brazil
- +1 more
Nov 8, 2021
Autonomic Nervous System Disorders, Pure Autonomic Failure, Shy-Drager Syndrome Trial in Nashville (Angiotensin-(1-7), Saline)
Terminated
- Autonomic Nervous System Disorders
- +3 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 8, 2021
Angiotensin/Renin/Aldosterone Hypertension, Hypertension, Diabetes, Type 2 Trial in Seongnam (Olmesartan)
Recruiting
- Angiotensin/Renin/Aldosterone Hypertension
- +2 more
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National University Bundang Hospital
Aug 16, 2022
DMD-Associated Dilated Cardiomyopathy Trial in Jerusalem, Ramat Gan (talfirastide)
Recruiting
- DMD-Associated Dilated Cardiomyopathy
-
Jerusalem, Israel
- +1 more
Aug 31, 2023
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Recruiting
- Hypertension
- +17 more
-
Winston-Salem, North CarolinaWake Forest Health Sciences
Jan 3, 2023
COVID-19 Trial in Istanbul (Biological/Vaccine: Angiotensin peptide (1-7) derived plasma)
Completed
- COVID-19
- Biological/Vaccine: Angiotensin peptide (1-7) derived plasma
-
Istanbul, TurkeyKanuni Sultan Suleyman Training and Research Hospital
Mar 30, 2022
Chronic Heart Failure, Cognitive Impairment Trial in Tucson (Angiotensin-(1-7), Memory Training)
Suspended
- Chronic Heart Failure
- Cognitive Impairment
- Angiotensin-(1-7)
- Memory Training
-
Tucson, ArizonaUniversity of Arizona Sarver Heart Center
Jul 23, 2021
Coronavirus, Respiratory Failure, Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere Trial (Angiotensin 1-7,
Not yet recruiting
- Coronavirus
- +3 more
- Angiotensin 1-7
- Placebos
- (no location specified)
Jul 30, 2021
COVID-19 Trial in Haifa (Angiotensin 1-7)
Recruiting
- COVID-19
- Angiotensin 1-7
-
Haifa, IsraelRambam Medical Center
Jan 18, 2021
Breast Carcinoma, Colorectal Adenocarcinoma, Bladder Carcinoma Trial run by the National Cancer Institute (NCI) (Recombinant
Recruiting
- Breast Carcinoma
- +2 more
- Recombinant human IL-7-hyFc (NT-I7)
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Coronavirus Disease(COVID)-19 Acute Respiratory Distress
Recruiting
- COVID
- Acute Respiratory Distress Syndrome
- Angiotensin II
- Interleukin-1 receptor antagonist
-
London, United KingdomGuy's & St Thomas' Hospital
Aug 3, 2021
Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure NYHA Class IV Trial in Phoenix, Tucson (Angiotensin
Not yet recruiting
- Heart Failure NYHA Class II
- +2 more
- Angiotensin 1-7
- Saline solution
-
Phoenix, Arizona
- +1 more
Apr 12, 2022
Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,
Terminated
- Double Cord Blood Transplant
- +8 more
- TXA127 300 mcg/kg/day
- TXA127 1000 mcg/kg/day
-
Houston, TexasMD Anderson Cancer Center
Dec 7, 2020
Idiopathic CD4 Lymphopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Recombinant human
Not yet recruiting
- Idiopathic CD4 Lymphopenia
- Recombinant human interleukin (IL) 7-hyFc
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Recombinant Interleukin-7
-
Houston, TexasM D Anderson Cancer Center
Jan 26, 2023
Dystrophic Epidermolysis Bullosa Trial in Stanford (Topical beremagene geperpavec)
Completed
- Dystrophic Epidermolysis Bullosa
- Topical beremagene geperpavec
- Placebo gel
-
Stanford, CaliforniaStanford University
Jan 30, 2023
Coronary Artery Bypass Surgery, Cognitive Impairment Trial in United States (Angiotensin-(1-7), Placebo for Angiotensin-(1-7))
Suspended
- Coronary Artery Bypass Surgery
- Cognitive Impairment
- Angiotensin-(1-7)
- Placebo for Angiotensin-(1-7)
-
Phoenix, Arizona
- +4 more
Nov 4, 2020
AIDS-Related Kaposi Sarcoma, HIV Infection, Kaposi Sarcoma Trial in San Francisco, Bethesda, Seattle (Efineptakin alfa)
Recruiting
- AIDS-Related Kaposi Sarcoma
- +2 more
- Efineptakin alfa
-
San Francisco, California
- +2 more
Aug 9, 2022
HIV Infection Trial in Badalona (ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).,
Recruiting
- HIV Infection
- ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).
- Normal saline solution
-
Badalona, Barcelona, SpainGermans Trias i Pujol Hospital
Jul 11, 2022